Longevity Health Holdings, Inc.
XAGE · OTCMCIK 1842939fmd_0Y1NEGZC6Q9Q5KSQYN2E3872WQManufacturing · Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsTemplate: Standard
Coverage: Jan 21, 2021 to Jun 30, 2026, 21 periods
Latest annual · FY2025
Millions- Total revenues
- 2
- Gross profit
- 1
- Operating income
- (7)
- Net income
- (7)
- Free cash flow
- (3)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
Longevity Health Holdings, Inc. (XAGE) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $1.9 million | $50,318 | +3,701.4% | 10-K 2026-03-31 · proof |
| Gross profit | $1.1 million | $43,961 | +2,390.3% | 10-K 2026-03-31 · proof |
| Operating income | -$7.1 million | -$5 million | 10-K 2026-03-31 · proof | |
| Net income | -$6.9 million | -$10.4 million | 10-K 2026-03-31 · proof | |
| Cash from operating activities | -$3.3 million | -$3.9 million | 10-K 2026-03-31 · proof | |
| Free cash flow | -$3.3 million | 10-K 2026-03-31 · proof | ||
| Total assets | $2.4 million | $1.5 million | +60.6% | 10-K 2026-03-31 · proof |
| Total liabilities | $8.2 million | $6.2 million | +33.1% | 10-K 2026-03-31 · proof |
| Cash and cash equivalents | $706,740 | $157,139 | +349.8% | 10-K 2026-03-31 · proof |
- What was Longevity Health Holdings, Inc. (XAGE)'s revenue in fiscal 2025?
- Longevity Health Holdings, Inc. (XAGE) reported revenue of $1.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $50,318 the year before (+3,701.4%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Longevity Health Holdings, Inc. (XAGE)'s gross profit in fiscal 2025?
- Longevity Health Holdings, Inc. (XAGE) reported gross profit of $1.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $43,961 the year before (+2,390.3%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Longevity Health Holdings, Inc. (XAGE)'s operating income in fiscal 2025?
- Longevity Health Holdings, Inc. (XAGE) reported operating income of -$7.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Longevity Health Holdings, Inc. (XAGE)'s net income in fiscal 2025?
- Longevity Health Holdings, Inc. (XAGE) reported net income of -$6.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$10.4 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Longevity Health Holdings, Inc. (XAGE)'s cash from operating activities in fiscal 2025?
- Longevity Health Holdings, Inc. (XAGE) reported cash from operating activities of -$3.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$3.9 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Longevity Health Holdings, Inc. (XAGE)'s free cash flow in fiscal 2025?
- Longevity Health Holdings, Inc. (XAGE) reported free cash flow of -$3.3 million for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Longevity Health Holdings, Inc. (XAGE)'s total assets?
- As of Dec 31, 2025, Longevity Health Holdings, Inc. (XAGE) reported total assets of $2.4 million, against $1.5 million a year earlier (+60.6%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Longevity Health Holdings, Inc. (XAGE)'s total liabilities?
- As of Dec 31, 2025, Longevity Health Holdings, Inc. (XAGE) reported total liabilities of $8.2 million, against $6.2 million a year earlier (+33.1%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Longevity Health Holdings, Inc. (XAGE)'s cash and cash equivalents?
- As of Dec 31, 2025, Longevity Health Holdings, Inc. (XAGE) reported cash and cash equivalents of $706,740, against $157,139 a year earlier (+349.8%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:XAGE&period_type=annual&limit=5"Information only, not investment advice.